Moderna

To much of the world, it seemed like the Covid-19 vaccines were whipped up in less than a year—an amazing feat of science and biotechnology if ever there was one. While the vaccines did get fast-tracked through clinical trial and … Read more

NPR’s sites use cookies, similar tracking and storage technologies, and information about the device you use to access our sites (together, “cookies”) to enhance your viewing, listening and user experience, personalize content, personalize messages from NPR’s sponsors, provide social media … Read more

Moderna, the biotech company that developed one of the first COVID-19 vaccines last year, is hoping to break new ground this week in fighting another pandemic: HIV/AIDS. The company will soon begin human trials for their mRNA-based vaccine, according to … Read more

Abstract Although clinical trials and real-world studies have affirmed the effectiveness and safety of the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent emergence of new variants highlight the need to vigilantly monitor the effectiveness of these vaccines. Here … Read more

A Phase 1 study for a RSV vaccine candidate is also under way. As part of its Vaccine Day this week, the company has updated its vaccine development timeline and unveiled results from early stage mRNA vaccine trials. HIV vaccines: mRNA-1644 … Read more

Assemblies-of-putative-SARS-CoV2-spike-encoding-mRNA-sequences-for-vaccines-BNT-162b2-and-mRNA-1273/Assemblies of putative SARS-CoV2-spike-encoding mRNA sequences for vaccines BNT-162b2 and mRNA-1273.docx.pdf at main · NAalytics/Assemblies-of-putative-SARS-CoV2-spike-encoding-mRNA-sequences-for-vaccines-BNT-162b2-and-mRNA-1273 · GitHub {{ message }} Permalink 1 contributor Sorry, something went wrong. Reload? Sorry, we cannot display this file. Sorry, this file is invalid so … Read more